Mitchell Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,689
| Closed | -$1.17M | – | 118 |
|
|
2023
Q4 | $1.17M | Sell |
8,689
-357
| -4% | -$46.4K | 0.25% | 85 |
|
|
2023
Q3 | $1.23M | Sell |
9,046
-61
| -0.7% | -$8.33K | 0.29% | 81 |
|
|
2023
Q2 | $1.3M | Buy |
9,107
+426
| +5% | +$62.7K | 0.3% | 83 |
|
|
2023
Q1 | $1.21M | Buy |
8,681
+34
| +0.4% | +$4.57K | 0.3% | 87 |
|
|
2022
Q4 | $1.17M | Buy |
8,647
+20
| +0.2% | +$2.51K | 0.32% | 89 |
|
|
2022
Q3 | $946K | Sell |
8,627
-253
| -3% | -$32.1K | 0.27% | 94 |
|
|
2022
Q2 | $1.17M | Buy |
8,880
+97
| +1% | +$12.7K | 0.33% | 83 |
|
|
2022
Q1 | $1.17M | Buy |
8,783
+483
| +6% | +$57.9K | 0.26% | 95 |
|
|
2021
Q4 | $967K | Buy |
8,300
+48
| +0.6% | +$5.65K | 0.2% | 105 |
|
|
2021
Q3 | $991K | Buy |
8,252
+131
| +2% | +$15.2K | 0.22% | 111 |
|
|
2021
Q2 | $973K | Buy |
8,121
+618
| +8% | +$67.8K | 0.21% | 116 |
|
|
2021
Q1 | $746K | Buy |
7,503
+1,384
| +23% | +$139K | 0.18% | 123 |
|
|
2020
Q4 | $612K | Sell |
6,119
-5,034
| -45% | -$533K | 0.15% | 119 |
|
|
2020
Q3 | $1.22M | Sell |
11,153
-113
| -1% | -$12.6K | 0.35% | 82 |
|
|
2020
Q2 | $1.19M | Sell |
11,266
-1,106
| -9% | -$114K | 0.38% | 79 |
|
|
2020
Q1 | $1.1M | Buy |
12,372
+1,209
| +11% | +$114K | 0.43% | 74 |
|
|
2019
Q4 | $1.11M | Sell |
11,163
-160
| -1% | -$15.1K | 0.35% | 77 |
|
|
2019
Q3 | $1.01M | Buy |
11,323
+1,576
| +16% | +$137K | 0.34% | 83 |
|
|
2019
Q2 | $805K | Buy |
9,747
+160
| +2% | +$12.5K | 0.27% | 88 |
|
|
2019
Q1 | $775K | Sell |
9,587
-589
| -6% | -$46.4K | 0.27% | 84 |
|
|
2018
Q4 | $773K | Sell |
10,176
-12
| -0.1% | -$937 | 0.33% | 70 |
|
|
2018
Q3 | $806K | Buy |
10,188
+1,677
| +20% | +$127K | 0.26% | 74 |
|
|
2018
Q2 | $598K | Buy |
8,511
+1,959
| +30% | +$141K | 0.22% | 75 |
|
|
2018
Q1 | $458K | Buy |
6,552
+2,552
| +64% | +$177K | 0.17% | 76 |
|
|
2017
Q4 | $278K | Buy |
4,000
+890
| +29% | +$60K | 0.1% | 77 |
|
|
2017
Q3 | $211K | Buy |
+3,110
| New | +$196K | 0.08% | 63 |
|
Other funds holding AZN
